Multiplex fluorescent immunoassay for detection of mice infected with lactate dehydrogenase elevating virus

Journal of the American Association for Laboratory Animal Science

Volumn 52, Issue 3, 2013, Pages 253-258

  Adams, Veronica ^a   Myles, Matthew H ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b IDEXX RADIL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; IMMUNOASSAY; INTERMETHOD COMPARISON; LACTATE DEHYDROGENASE BLOOD LEVEL; LACTATE DEHYDROGENASE ELEVATING VIRUS; MOUSE; MULTIPLEX FLUORESCENT IMMUNOASSAY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA VIRUS; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY; SWISS WEBSTER MOUSE; VIRUS GENOME; VIRUS INFECTION;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY COMPLEX; ARTERIVIRUS INFECTIONS; B-LYMPHOCYTES; ENZYME ASSAYS; FEMALE; IMMUNOASSAY; L-LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS; RODENT DISEASES;

EID: 84877755382     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Bailey JM, Clough J, Stearman M. 1964. Clearance of plasma enzymes in normal and LDH-agent-infected mice. Proc Soc Exp Biol Med 117: 350-354.
2. Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Semenova V, Steward-Clark E, Stamey K, Freeman AE, Quinn CP, Snawder JE. 2004. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin Diagn Lab Immunol 11: 50-55.
3. Brinton-Darnell M, Brand I. 1977. Delayed foreign-body tumorigenesis in mice infected with lactate dehydrogenase elevating virus: brief communication. J Natl Cancer Inst 59: 1027-1029.
4. Cafruny WA, Bradley SE, Rowland RR. 1999. Regulation of immune complexes during infection of mice with lactate dehydrogenase elevating virus: studies with interferon-γ gene knockout and tolerant mice. Viral Immunol 12: 163-173.
5. Cafruny WA, Chan SP, Harty JT, Yousefi S, Kowalchyk K, Mc- Donald D, Foreman B, Budweg G, Plagemann PG. 1986. Antibody response of mice to lactate dehydrogenase elevating virus during infection and immunization with inactivated virus. Virus Res 5: 357-375.
6. Cafruny WA, Heruth DP, Jaqua MJ, Plagemann PG. 1986. Immunoglobulins that bind to uncoated ELISA plate surfaces: appearance in mice during infection with lactate dehydrogenase elevating virus and in human antinuclear-antibody- positive sera. J Med Virol 19: 175-186.
7. Cafruny WA, Plagemann PG. 1982. Immune response to lactate dehydrogenase elevating virus: isolation of infectious virus- immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Infect Immun 37: 1001-1006.
8. Cafruny WA, Plagemann PG. 1982. Immune response to lactate dehydrogenase elevating virus: serologically specific rabbit neutralizing antibody to the virus. Infect Immun 37: 1007-1012.
9. Chan SP, Onyekaba CO, Harty JT, Plagemann PG. 1989. Persistent infection of mice by lactate dehydrogenase elevating virus: transient virus replication in macrophages of the spleen. Virus Res 14: 317-326.
10. Chen Z, Plagemann PG. 1997. Detection of lactate dehydrogenase elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell. J Virol Methods 65: 227-236.
11. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183: 109-117.
12. Coutelier JP, Coulie PG, Wauters P, Heremans H, van der Logt JT. 1990. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol 64: 5383-5388.
13. Coutelier JP, van der Logt JT, Heessen FW, Vink A, van Snick J. 1988. Virally induced modulation of murine IgG antibody subclasses. J Exp Med 168: 2373-2378.
14. Coutelier JP, Van Roost E, Lambotte P, Van Snick J. 1986. The murine antibody response to lactate dehydrogenase elevating virus. J Gen Virol 67: 1099-1108.
15. Coutelier JP, Van Snick J. 1985. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol 15: 250-255.
16. Dillberger JE, Monroy P, Altman NH. 1987. The effect of 3 bleeding techniques on lactic dehydrogenase levels in mice: implications for lactic dehydrogenase virus bioassay. Lab Anim Sci 37: 356-359.
17. Fox J, Anderson LC, Loew FM, Quimby FW, editors. 2002. Laboratory animal medicine, 2nd ed. San Diego (CA): Academic Press.
18. Fox J, Barthold SW, Davisson MT, Newcomer CE, Quimby FW, Smith AL, editors. 2007. The Mouse in biomedical research: diseases. New York (NY): Elsevier.
19. Frith CH, Suber RL, Umholtz R. 1980. Hematologic and clinical chemistry findings in control BALB/c and C57BL/6 mice. Lab Anim Sci 30: 835-840.
20. Goto K, Takakura A, Yoshimura M, Ohnishi Y, Itoh T. 1998. Detection and typing of lactate dehydrogenase elevating virus RNA from transplantable tumors, mouse liver tissues, and cell lines, using PCR. Lab Anim Sci 48: 99-102.
21. Hayashi T, Iwata H, Hasegawa T, Ozaki M, Yamamoto H, Onodera T. 1991. Decrease in neutrophil migration induced by endotoxin and suppression of interleukin 1 production by macrophages in lactic dehydrogenase virus-infected mice. J Comp Pathol 104: 161-170.
22. Hayashi T, Ozaki M, Mori I, Saito M, Itoh T, Yamamoto H. 1992. Enhanced clearance of lactic dehydrogenase 5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance. Int J Exp Pathol 73: 173-181.
23. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169: 59-72.
24. Hsu CC, Franklin C, Riley LK. 2007. Multiplex fluorescent immunoassay for the simultaneous detection of serum antibodies to multiple rodent pathogens. Lab Anim (NY) 36: 36-38.
25. Hu B, Even C, Plagemann PG. 1992. Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase elevating virus: relationship to IgG2a- and IgG2bspecific polyclonal activation of B cells. Viral Immunol 5: 27-38.
26. Isakov N, Feldman M, Segal S. 1981. Effect of lactic dehydrogenase virus infection on tumor induction and tumor growth. Cancer Res 41: 667-672.
27. Khan IH, Kendall LV, Ziman M, Wong S, Mendoza S, Fahey J, Griffey SM, Barthold SW, Luciw PA. 2005. Simultaneous serodetection of 10 highly prevalent mouse infectious pathogens in a single reaction by multiplex analysis. Clin Diagn Lab Immunol 12: 513-519.
28. Lipman NS, Henderson K, Shek W. 2000. False-negative results using RT-PCR for detection of lactate dehydrogenase elevating virus in a tumor cell line. Comp Med 50: 255-256.
29. Markine-Goriaynoff D, Hulhoven X, Cambiaso CL, Monteyne P, Briet T, Gonzalez MD, Coulie P, Coutelier JP. 2002. Natural killer cell activation after infection with lactate dehydrogenase elevating virus. J Gen Virol 83: 2709-2716.
30. McDonald TL, Donnelly T, Weber A, Quenette L. 1983. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus. Immunology 48: 511-517.
31. Michaelides MC, Schlesinger S. 1974. Effect of acute or chronic infection with lactic dehydrogenase virus (LDV) on the susceptibility of mice to plasmacytoma MOPC-315. J Immunol 112: 1560-1564.
32. Monteyne P, Van Broeck J, Van Snick J, Coutelier JP. 1993. Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. Cytokine 5: 394-397.
33. Morimoto M, Iwata H, Hayashi T. 1999. Lactic dehydrogenase virus infection inhibits allergic eosinophil reaction and IL5 gene expression in vivo. Int Arch Allergy Immunol 120: 78-84.
34. Notkins AL. 1971. Enzymatic and immunologic alterations in mice infected with lactic dehydrogenase virus. Am J Pathol 64: 733-746.
35. Notkins AL, Mergenhagen SE, Rizzo AA, Scheele C, Waldmann TA. 1966. Elevated γ-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med 123: 347-364.
36. Notkins AL, Shochat SJ. 1963. Studies on the multiplication and the properties of the lactic dehydrogenase agent. J Exp Med 117: 735-747.
37. Percy D, Barthold SW. 2007. Pathology of laboratory rodents and rabbits, 3rd ed. Ames (IA): Blackwell Publishing Professional.
38. Plagemann PG, Gregory KF, Swim HE, Chan KKW. 1963. Plasma lactic dehydrogenase elevating agent of mice: distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Can J Microbiol 9: 75-86.
39. Plagemann PG, Watanabe M, Swim HE. 1962. Plasma lactic dehydrogenase elevating agent of mice: effect on levels of additional enzymes. Proc Soc Exp Biol Med 111: 749-754.
40. Porter DD, Porter HG, Deerhake BB. 1969. Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice. J Immunol 102: 431-436.
41. Riley V, Lilly F, Huerto E, Bardell D. 1960. Transmissible agent associated with 26 types of experimental mouse neoplasms. Science 132: 545-547.
42. Ritzi DM, Holth M, Smith MS, Swart WJ, Cafruny WA, Plagemann GW, Stueckemann JA. 1982. Replication of lactate dehydrogenase elevating virus in macrophages. 1. Evidence for cytocidal replication. J Gen Virol 59: 245-262.
43. Rowland RR, Even C, Anderson GW, Chen Z, Hu B, Plagemann PG. 1994. Neonatal infection of mice with lactate dehydrogenase elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. J Gen Virol 75: 1071-1081.
44. Snodgrass MJ, Lowrey DS, Hanna MG Jr. 1972. Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. J Immunol 108: 877-892.
45. Stevenson MM, Rees JC, Meltzer MS. 1980. Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes. J Immunol 124: 2892-2899.
46. Stueckemann JA, Holth M, Swart WJ, Kowalchyk K, Smith MS, Wolstenholme AJ, Cafruny WA, Plagemann PG. 1982. Replication of lactate dehydrogenase elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. J Gen Virol 59: 263-272.
47. van der Logt JT, Kissing J, Melchers WJ. 1994. Enzymatic amplification of lactate dehydrogenase elevating virus. J Clin Microbiol 32: 2003-2006.
48. Wagner AM, Loganbill JK, Besselsen DG. 2004. Detection of lactate dehydrogenase elevating virus by use of a fluorogenic nuclease RT-PCR assay. Comp Med 54: 288-292.
49. Weiland E, Grossmann A, Thiel HJ, Weiland F. 1990. Lactate dehydrogenase elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants. J Gen Virol 71: 1233-1236.
50. Yucel D, Dalva K. 1992. Effect of in vitro hemolysis on 25 common biochemical tests. Clin Chem 38: 575-577.